Vaccine News and Research

Latest Vaccine News and Research

New vaccine containing DNA and recombinant proteins may protect from HIV

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins?proteins composed of a portion of an HIV protein and another unrelated protein.

24 Jul 2019

Study provides 'strongest evidence' yet for autism being a genetic condition

A new study has found that approximately 80 percent of a person’s risk of developing autism stems from inherited genetic factors.

22 Jul 2019

Fear, trust, likelihood of exposure influence people’s willingness to be vaccinated

Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.

19 Jul 2019

Study uncovers gene that hides tumor cells from immunotherapy

A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients.

19 Jul 2019

Women's greater immune response to flu vaccine declines with age

Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.

17 Jul 2019

Novel vaccine against bee sting allergy successfully tested

A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.

17 Jul 2019

Researchers find mechanism behind susceptibility to viral infections

A team of researchers from the SingHealth Duke-NUS Academic Medicine Centre's Viral Research and Experimental Medicine Centre found that immune cells undergoing stress and an altered metabolism are the reasons why some individuals become sick from viral infections while others do not, when exposed to the same virus.

16 Jul 2019

Removing bacterial armor could be new way to fight anthrax

A new study led by Dr. Antonella Fioravanti in the lab of Prof. Han Remaut (VIB-VUB Center for Structural Biology) has shown that removing the armor of the bacterium that causes anthrax slows its growth and negatively affects its ability to cause disease.

16 Jul 2019

HIV therapy leaves unrepaired holes in the immune system's wall of defense

If they don't receive antiretroviral therapy (ART), most HIV patients see a progressive weakening of their immune system.

16 Jul 2019

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

16 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA.

11 Jul 2019

British boys to receive HPV jabs

From this September, boys of 12 and 13 will receive the HPV vaccine in all UK schools, hopefully preventing mouth, throat, penile and anal cancers caused by this oncovirus.

10 Jul 2019

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

The University of Montana has received a $3.3 million contract from the National Institutes of Health to develop an innovative vaccine targeting opioid addiction.

10 Jul 2019

Australia leads the world in childhood immunization coverage

Even as Australia reels under a deadly flu season, some solace may be found in the fact that almost 95% of of five-year-old Australian children are almost completely immunized against deadly childhood diseases, according to the latest report.

8 Jul 2019

Number of fully-immunized Australian kids hits record high

New data for the March quarter in 2019 revealed the immunization rates for all five-year-old children in the country increased to 94.78 percent from the previous record of 94.67 percent in December 2018.

7 Jul 2019

Researchers study the role of nasal ecosystem and viral infection on pneumococcal acquisition

Researchers at LSTM, along with colleagues at the University of Edinburgh and the University Medical Center Utrecht have looked at the impact of the natural microbial flora or microbiota in the nose and viral co-infection on pneumococcal acquisition in healthy adults.

5 Jul 2019